Regulatory approval of the first two therapeutic substances for the management of
geographic atrophy (GA) secondary to age-related macular degeneration (AMD) is a major …

Purpose: To determine the impact of topographic locations on the progression rate of
geographic atrophy (GA). Methods: We searched in five literature databases up to May 3 …

Purpose To quantitatively measure hyperreflective foci (HRF) during the progression of
geographic atrophy (GA) secondary to age-related macular degeneration (AMD) using deep …

Purpose: To investigate the impact of subretinal drusenoid deposits (SDD) and
photoreceptor integrity on global and local geographic atrophy (GA) progression. Methods …

Purpose The retinal pigment epithelium (RPE) to Bruch membrane (BM) distance around
geographic atrophy (GA) was measured using an optical attenuation coefficient (OAC) …

Objectives To investigate the impact of qualitatively graded and deep learning quantified
imaging biomarkers on growth of geographic atrophy (GA) secondary to age-related …

Purpose To investigate the underlying reason for the previously observed impact of baseline
lesion size, number, and circularity on geographic atrophy (GA) growth rate. Design …

Introduction: There is no effective treatment for geographic atrophy (GA). To help design
future GA treatment trials, we conducted a meta-analysis for GA growth rate and its variability …

Background/aims Best-corrected visual acuity (BCVA) is the most common primary endpoint
in treatment trials for choroideremia (CHM) but the long-term natural history of BCVA is …

Topic Systematic review and meta-analysis of the natural history of autosomal recessive
Stargardt disease (STGD1). Clinical Relevance Controversy exists regarding the …